Market Cap 37.61B
Revenue (ttm) 9.91B
Net Income (ttm) 1.02B
EPS (ttm) N/A
PE Ratio 25.30
Forward PE 24.69
Profit Margin 10.27%
Debt to Equity Ratio 0.21
Volume 1,361,700
Avg Vol 2,314,524
Day's Range N/A - N/A
Shares Out 493.24M
Stochastic %K 79%
Beta 0.99
Analysts Strong Sell
Price Target $96.01

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system,...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 41 589 112 110
Address:
Chemin de Blandonnet 8, Vernier, Geneva, Switzerland
StocktwitsNews
StocktwitsNews Oct. 23 at 5:27 PM
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-stock-rises-after-adjournment-of-stockholders-meeting-to-discuss-proposed-merger-with-alcon/cLG4FXDR3rj
0 · Reply
Mergerbrief
Mergerbrief Oct. 23 at 12:21 PM
$STAA / $ALC - Shareholder Vote $STAA MergerBrief.com
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 7:21 PM
Broadwood Partners, L.P., the largest shareholder of STAAR Surgical, announced plans to call a special meeting to remove several board members, intensifying its campaign against STAAR’s proposed $28-per-share sale to Alcon AG. Broadwood said the move follows “overwhelming opposition” to the deal and warned directors not to delay the upcoming shareholder vote or modify the agreement without “meaningful input and alignment with shareholders.” Founder and Chairman Neal C. Bradsher stated that the current board “no longer has shareholders’ confidence” and called for new directors to lead a transparent review of strategic alternatives “free from conflicts and process flaws” seen in the Alcon deal. The announcement comes after growing pressure on STAAR’s board. $STAA $ALC
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 1:04 PM
Keybanc has updated their rating for Alcon ( $ALC ) to Overweight with a price target of 91.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 13 at 6:50 PM
0 · Reply
JarvisFlow
JarvisFlow Oct. 13 at 12:09 PM
BTIG has adjusted their stance on Alcon ( $ALC ), setting the rating to Buy with a target price of 92 → 91.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 2:16 PM
List 9/26/25 $ALC $ALE $ALKS $ALLE 🔥 Cycle Trading Signal plugged into AI 🔥
1 · Reply
StockHunter75
StockHunter75 Oct. 3 at 2:26 PM
$ALC Going to rip higher imo
1 · Reply
StockHunter75
StockHunter75 Oct. 2 at 3:19 PM
$ALC time to start piling in.
0 · Reply
lexlut
lexlut Sep. 30 at 1:40 PM
0 · Reply
Latest News on ALC
Alcon to Present at 2025 Baird Global Healthcare Conference

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Alcon to Present at 2025 Baird Global Healthcare Conference


Trouble Ahead for Alcon Shares

Aug 22, 2025, 10:28 AM EDT - 2 months ago

Trouble Ahead for Alcon Shares


These Analysts Slash Their Forecasts On Alcon After Q2 Earnings

Aug 21, 2025, 8:48 AM EDT - 2 months ago

These Analysts Slash Their Forecasts On Alcon After Q2 Earnings


Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript

Aug 20, 2025, 9:10 PM EDT - 2 months ago

Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript


Alcon: More Than Meets The Eye

Aug 20, 2025, 11:33 AM EDT - 2 months ago

Alcon: More Than Meets The Eye


Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

Aug 20, 2025, 5:03 AM EDT - 2 months ago

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit


Alcon Agrees to Acquire STAAR Surgical

Aug 5, 2025, 1:01 AM EDT - 2 months ago

Alcon Agrees to Acquire STAAR Surgical

STAA


Alcon Canada Earns Global Recognition as a Top Employer

Jun 26, 2025, 9:03 AM EDT - 4 months ago

Alcon Canada Earns Global Recognition as a Top Employer


US FDA approves Alcon's new dry-eye drug

May 28, 2025, 5:47 PM EDT - 5 months ago

US FDA approves Alcon's new dry-eye drug


Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript

May 14, 2025, 12:03 PM EDT - 5 months ago

Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript


StocktwitsNews
StocktwitsNews Oct. 23 at 5:27 PM
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-stock-rises-after-adjournment-of-stockholders-meeting-to-discuss-proposed-merger-with-alcon/cLG4FXDR3rj
0 · Reply
Mergerbrief
Mergerbrief Oct. 23 at 12:21 PM
$STAA / $ALC - Shareholder Vote $STAA MergerBrief.com
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 7:21 PM
Broadwood Partners, L.P., the largest shareholder of STAAR Surgical, announced plans to call a special meeting to remove several board members, intensifying its campaign against STAAR’s proposed $28-per-share sale to Alcon AG. Broadwood said the move follows “overwhelming opposition” to the deal and warned directors not to delay the upcoming shareholder vote or modify the agreement without “meaningful input and alignment with shareholders.” Founder and Chairman Neal C. Bradsher stated that the current board “no longer has shareholders’ confidence” and called for new directors to lead a transparent review of strategic alternatives “free from conflicts and process flaws” seen in the Alcon deal. The announcement comes after growing pressure on STAAR’s board. $STAA $ALC
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 1:04 PM
Keybanc has updated their rating for Alcon ( $ALC ) to Overweight with a price target of 91.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 13 at 6:50 PM
0 · Reply
JarvisFlow
JarvisFlow Oct. 13 at 12:09 PM
BTIG has adjusted their stance on Alcon ( $ALC ), setting the rating to Buy with a target price of 92 → 91.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 2:16 PM
List 9/26/25 $ALC $ALE $ALKS $ALLE 🔥 Cycle Trading Signal plugged into AI 🔥
1 · Reply
StockHunter75
StockHunter75 Oct. 3 at 2:26 PM
$ALC Going to rip higher imo
1 · Reply
StockHunter75
StockHunter75 Oct. 2 at 3:19 PM
$ALC time to start piling in.
0 · Reply
lexlut
lexlut Sep. 30 at 1:40 PM
0 · Reply
TalkMarkets
TalkMarkets Sep. 27 at 3:20 AM
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI $MASI $COLL Also $ALC $SONVY https://talkmarkets.com/content/stocks--equities/dont-overlook-these-2-highly-ranked-medical-stocks-coll-masi?post=525107
0 · Reply
SweepCastApp
SweepCastApp Sep. 26 at 12:03 PM
$ALC: TRADE CALL trade alert 13 @ 23.50, Strike 60.0, Exp 1/21/2028, Premium $30,550, Sentiment BULLISH
0 · Reply
RunnerSignals
RunnerSignals Sep. 24 at 6:58 AM
$CRWD $AVGO $ALC riding the AI wave! Analysts see MASSIVE upside - some targets hitting 325%! $MBX biotech heating up too https://stocksrunner.com/news/2025-09-23-analysts-eye-major-upside-targets
0 · Reply
StockHunter75
StockHunter75 Sep. 23 at 2:20 PM
$ALC Going long here
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 22 at 12:37 PM
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-shareholder-yunqi-capital-opposes-proposed-merger-with-alcon/chDQFDHR32a
0 · Reply
ZacksResearch
ZacksResearch Sep. 19 at 12:23 PM
$ALC: Visionary growth or costly hurdles ahead? 👀 Alcon’s Vision Care and Surgical divisions are thriving with innovative products like Vivity and PanOptix, but macroeconomic pressures and intense competition loom large. Tariff-related charges are expected to impact costs by $100M in 2025. ⚠️ Explore the full analysis here 👉 https://www.zacks.com/stock/news/2753851/is-it-a-prudent-move-to-retain-alc-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2753851-body-13207&ADID=SYND_STOCKTWITS_TWEET_2_2753851_BODY_13207
0 · Reply
ZacksResearch
ZacksResearch Sep. 19 at 11:23 AM
$ALC — Hold or fold? 👀 Growth from surgical innovation and vision care is promising, but macro headwinds and competition are real risks. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2753851/is-it-a-prudent-move-to-retain-alc-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2753851-teaser-13206&ADID=SYND_STOCKTWITS_TWEET_2_2753851_TEASER_13206
0 · Reply
ZacksResearch
ZacksResearch Sep. 18 at 1:46 PM
$ALC reports efficiency gains with UNITY VCS compared to other systems in eye surgery 👁️ ✅ 16% workflow efficiency boost in vitreoretinal surgery ✅ 6% faster cataract surgery turnover with reduced energy & ultrasound time Discover how Alcon's innovation could influence market trends 👉 https://www.zacks.com/stock/news/2753227/alcons-unity-vcs-shows-superior-efficiency-in-studies-stock-up?cid=sm-stocktwits-2-2753227-body-13001&ADID=SYND_STOCKTWITS_TWEET_2_2753227_BODY_13001
0 · Reply
ZacksResearch
ZacksResearch Sep. 18 at 12:46 PM
$ALC just popped on UNITY VCS 🚀 — game changer for eye surgery? Studies showed faster, more efficient cataract and vitreoretinal procedures, and the stock is reacting. Full breakdown on what’s driving the move 👉 https://www.zacks.com/stock/news/2753227/alcons-unity-vcs-shows-superior-efficiency-in-studies-stock-up?cid=sm-stocktwits-2-2753227-teaser-13000&ADID=SYND_STOCKTWITS_TWEET_2_2753227_TEASER_13000
0 · Reply
Abreu_Anesthesia
Abreu_Anesthesia Sep. 15 at 10:55 PM
$ALC https://finance.yahoo.com/news/broadwood-files-preliminary-proxy-block-223434966.html
0 · Reply
Jim1Winston
Jim1Winston Aug. 22 at 8:13 AM
$ALC How much will the stock price go up when the US tariff on Swiss products is reduced by 39% to 15..20%
0 · Reply
JarvisFlow
JarvisFlow Aug. 21 at 6:27 PM
Wells Fargo has adjusted their stance on Alcon ( $ALC ), setting the rating to Equal-Weight with a target price of 93 → 88.
0 · Reply